Clinical Trial Update: Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan

View source ↗

Summary

Completed clinical trial update examining outcomes in hormonal receptor-positive, HER2-negative breast cancer in Taiwan. The trial was sponsored by Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Pfizer | Conditions: ER/PR(+), Her2(-) Breast Cancer | Status: COMPLETED